GlassScriptPhysician profile
Charles C Cheng
NPI 1285626465
$2,286.51
in general payments reported to CMS, 2019-2025
9 companies · $977 in 2025
The $977 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.35 · 2020: $132 · 2022: $45.00 · 2023: $85.67 · 2024: $962 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,699 · Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,698.57 |
| Food and Beverage | $325.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,812.22 | 2024-2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Ethicon INC. | $126.66 | 2024 | Monarch Platform |
| Mauna Kea Technologies, INC. | $122.95 | 2020-2023 | |
| Intuitive Surgical, INC. | $71.57 | 2019 | |
| Boston Scientific Corporation | $62.33 | 2020 | |
| Ethicon US, LLC | $32.00 | 2020 | |
| Merck Sharp & Dohme LLC | $30.62 | 2022 | |
| Pinnacle Biologics, INC | $14.38 | 2022 | |
| Davol INC. | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.